E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Special Issue "Anti-Allergy Agents"

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (30 May 2013)

Special Issue Editors

Guest Editor
Dr. Rauno Joks

Center for Allergy and Asthma Research at SUNY Downstate, State University of New York Downstate Medical Center, Brooklyn, NY, USA
Interests: IgE; tetracycline; minocycline; complement; MAP kinase; neural control of IgE responses
Guest Editor
Dr. Helen G. Durkin

Center for Allergy and Asthma Research at SUNY Downstate, State University of New York Downstate Medical Center, Brooklyn, NY, USA
Interests: IgE; allergy; asthma; food allergy; HIV-1; thymus; brain; magnetic stimulation; neuropeptides; Peyer’s patches; bacterial cell wall components; peptidoglycan; tetracycline; minocycline; chemically modified tetracycine

Special Issue Information

Dear Colleagues,

Investigations into pathophysiologic mechanisms are revealing the pieces of the puzzle that is allergy, with new potential therapeutic targets emerging. This issue of Pharmaceuticals will present recent developments in our understanding of the etiopathogenesis of IgE responses, and provide a better understanding of present and potential treatments for this area of hypersensitivity which can affect more than 25% of the general population.

Dr. Rauno Joks
Dr. Helen G. Durkin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • immunolgobulin E
  • atopy
  • allergy
  • Corticosteroid
  • beta-agonist
  • anti-leukotriene therapy
  • omalizumab
  • mast cell
  • anti-interleukin-5 monoclonal therapy

Published Papers

This special issue is now open for submission.
Back to Top